Failure after radiochemotherapy
50.4 Gy/28 fractions concurrent with paclitaxel -carboplatinum
• >50% locoregional
• At 2 years
Versteijne et al. Diseases of the Esophagus
(2015)
28
, 453–
25
%
M
L
R
25% disease-free